Safety Update On Certolizumab Pegol in Patients with Active Rheumatoid Arthritis with Long Term Exposure

被引：0
|
作者：
Mariette, Xavier [1 ]
van Vollenhoven, Rf. [2 ]
Bykerk, Vivian P. [3 ]
de Longueville, Marc [4 ]
Arendt, Catherine [4 ]
Luijtens, Kristel [5 ]
Cush, John J. [6 ]
机构：
[1] Univ Paris 11, Le Kremlin Bicetre, France
[2] Karolinska Inst, Stockholm, Sweden
[3] Hosp Special Surg, New York, NY 10021 USA
[4] UCB Pharma, Brussels, Belgium
[5] UCB, Brussels, Belgium
[6] Baylor Res Inst, Dallas, TX USA
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
503
引用
收藏
页码：S221 / S221
页数：1
相关论文
共 50 条
  • [1] Safety Update on Certolizumab Pegol in Patients with Active Rheumatoid Arthritis with Long Term Exposure
    Mariette, Xavier
    Van Vollenhoven, Ronald
    Bykerk, Vivian
    de Longueville, Marc
    Arendt, Catherine
    Luijtens, Kristel
    Cush, Jack
    [J]. JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 1018 - 1018
  • [2] SAFETY UPDATE ON CERTOLIZUMAB PEGOL IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH LONG-TERM EXPOSURE
    Mariette, X.
    van Vollenhoven, Ronald F.
    Bykerk, V.
    de Longueville, M.
    Arendt, C.
    Luijtens, K.
    Cush, J.
    [J]. RHEUMATOLOGY, 2013, 52 : 86 - 86
  • [3] Safety Update on Certolizumab Pegol (CZP) in Patients with Active Rheumatoid Arthritis (RA)
    Van Vollenhoven, Ronald
    Smolen, Joseph
    Schiff, Michael
    Fleischmann, Roy
    Combe, Bernard
    Goel, Niti
    Desai, C.
    Curtis, Jeffrey
    Keystone, Edward
    [J]. JOURNAL OF RHEUMATOLOGY, 2010, 37 (06) : 1332 - 1332
  • [4] SAFETY UPDATE ON CERTOLIZUMAB PEGOL (CZP) IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS (RA)
    van Vollenhoven, Raymond
    Smolen, Josef
    Schiff, Michael
    Fleischmann, Roy
    Combe, Bernard
    Goel, Niti
    Desai, Chintu
    Curtis, Jeffery
    Keystone, Edward
    Emery, Paul
    Choy, Ernest
    [J]. RHEUMATOLOGY, 2010, 49 : I102 - I103
  • [5] Certolizumab pegol in active rheumatoid arthritis
    Aarat M. Patel
    Larry W. Moreland
    [J]. Current Rheumatology Reports, 2009, 11 (5) : 311 - 312
  • [6] Certolizumab pegol in rheumatoid arthritis: current update
    Fechtenbaum, Marie
    Yusof, Md Yuzaiful Md
    Emery, Paul
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (06) : 841 - 850
  • [7] EFFICACY AND SAFETY OF CERTOLIZUMAB PEGOL WITH METHOTREXATE IN RHEUMATOID ARTHRITIS PATIENTS
    Carlino, G.
    Cozzolongo, A.
    Maggio, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 1049 - 1049
  • [8] SAFETY OF CERTOLIZUMAB PEGOL IN RHEUMATOID ARTHRITIS PATIENTS WITH PREVIOUS HEPATITIS B VIRUS EXPOSURE
    Bello, S.
    Fanizzi, R.
    Serafino, L.
    Albanese, L.
    Bonali, C.
    Lapadula, G.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 436 - 436
  • [9] Long-Term Maintenance of Response in Patients with Rheumatoid Arthritis Treated with Certolizumab Pegol
    Saraux, Alain
    Flipo, Rene-Marc
    Fagnani, Francis
    Cukierman, Gabrielle
    Bru, Isabelle
    Joubert, Jean-Michel
    Schuller, Jan-Christof
    Massol, Jacques
    Combe, Bernard
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [10] Long-Term Maintenance of Certolizumab Pegol Safety and Efficacy, in Combination with Methotrexate and as Monotherapy, in Rheumatoid Arthritis Patients
    Fleischmann, Roy
    van Vollenhoven, Ronald F.
    Vencovsky, Jiri
    Alten, Rieke
    Davies, Owen
    Mountian, Irina
    de Longueville, Marc
    Carter, David
    Choy, Ernest
    [J]. RHEUMATOLOGY AND THERAPY, 2017, 4 (01) : 57 - 69
12345